Bo Magnusson
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
ASAH1 pathogenic variants associated with acid ceramidase deficiency: Farber disease and spinal muscular atrophy with progressive myoclonic epilepsy.
Journal: Human mutation
Published: November 26, 2019
The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patients.
Journal: Pediatric rheumatology online journal
Published: February 12, 2019
The European network for care of children with paediatric rheumatic diseases: care across borders.
Journal: Rheumatology (Oxford, England)
Published: July 31, 2018
Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries.
Journal: Arthritis research & therapy
Published: May 21, 2018
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.
Journal: Annals of the rheumatic diseases
Published: March 01, 2017
A survey of national and multi-national registries and cohort studies in juvenile idiopathic arthritis: challenges and opportunities.
Journal: Pediatric rheumatology online journal
Published: January 25, 2017
Acid Ceramidase Deficiency is characterized by a unique plasma cytokine and ceramide profile that is altered by therapy.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: July 07, 2016
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: February 11, 2016
Consensus-based recommendations for the management of juvenile dermatomyositis.
Journal: Annals of the rheumatic diseases
Published: January 22, 2016
Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial.
Journal: Lancet (London, England)
Published: December 10, 2015
Diverse effects on vaccine-specific serum IgG titres and memory B cells upon methotrexate and anti-TNF-α therapy in children with rheumatic diseases: A cross-sectional study.
Journal: Vaccine
Published: September 02, 2015
Perceived Oral Health and Care of Children with Juvenile Idiopathic Arthritis: A Qualitative Study.
Journal: Journal of oral & facial pain and headache
Published: August 06, 2015
Last Updated: 09/26/2026